A three-week schedule of gemcitabine plus cisplatin as induction chemotherapy for stage III non-small cell lung cancer (NSCLC): final results of a monoinstitutional phase II study

Autor: Migliorino, M.R., Nelli, F., Facciolo, F., Cipri, A., Belli, R., Ammaturo, M.V., Ariganello, O., Paoluzzi, L., Di Molfetta, M., De Marinis, F.
Zdroj: In European Journal of Cancer 2001 37 Supplement 6:S60-S60
Databáze: ScienceDirect
Externí odkaz: